Feed LNSR
LN

LENSAR, Inc. LNSR · NASDAQ

$5.80 -3.81% (-$0.23)

Market cap
$74.1M
Enterprise value
$62.9M
P/E
2.1x
Forward P/E
-
PEG
-
P/S
1.2x
P/FCF
-
EV/EBITDA
1.8x
ROIC
-22.0%
Gross margin
48.0%
Net margin
57.6%
Dividend yield
-
Payout ratio
-
Net debt/EBITDA
-0.3x
Beta
0.95
Free float
72.0%

About the company

LENSAR, Inc. (LSR) is an American company focused on the development and manufacturing of advanced technologies for surgical ophthalmology. With a product portfolio including innovative surgical systems like the LENSAR® Laser System, LENSAR provides state-of-the-art solutions for cataract procedures. Their technology combines advanced robotics, 3D imaging, and laser energy, enabling precise and personalized surgical interventions for patients. LENSAR, Inc. also emphasizes continuous development and innovation in the field of ophthalmic surgery. Shares of LENSAR, Inc. (LSR) could be suitable for investors seeking opportunities in the healthcare technology sector with a focus on ophthalmic surgery and innovative technologies.

Sector

Healthcare

Industry

Medical - Devices

CEO

Nicholas T. Curtis

Employees

150

Headquarters

Orlando

Valuation

Is today's price reasonable?

Growth and estimates

Is it growing, and what comes next?

Profitability and quality

How much of the revenue is left, and how well does the company use its capital?

Financial health

Can it carry its debt?

Capital and dividends

What does the company do with the money it earns?

Analysts

What do the professionals think, and is it changing?

Owners and insiders

Who holds the stock, and what is management doing?

Segments

Which part of the company is growing?

Peer comparison

How does it compare with similar companies?

Price and risk

How does the stock behave?

Statements

Every number

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.